Bystander effects are induced by CENU treatment and associated with altered protein secretory activity of treated tumor cells a relay for chemotherapy?

International Journal of Cancer

Volumn 119, Issue 5, 2006, Pages 992-1004

  Demidem, Aicha ^a   Morvan, Daniel ^b,c   Madelmont, Jean Claude ^a  

^a INSERM   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c Centre de Lutte Contre le Cancer Jean Perrin   (France)

Author keywords

Bystander effects; Chloroethylnitrosoureas; Distant double tumor models; Growth inhibition; Proteomics

Indexed keywords

ACTIN; CHLOROETHYLNITROSOUREA; CYCLOHEXIMIDE; CYSTEMUSTINE; HEAT SHOCK PROTEIN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; RHO ASSOCIATED COILED COIL FORMING KINASE 2; RHO KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BYSTANDER EFFECT; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; MASS SPECTROMETRY; MELANOMA; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; PROTEOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CELL; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ACTINS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BYSTANDER EFFECT; CELL PROLIFERATION; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ETHYLNITROSOUREA; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN-SERINE-THREONINE KINASES; UP-REGULATION;

EID: 33746353433     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21761     Document Type: Article

References (43)

1. Adris S, Chuluyan E, Bravo A, Berenstein M, Klein S, Jasnis M, Carbone C, Chernajovsky Y, Podhajcer OL. Mice vaccination with interleukin 12-transduced colon cells potentiates rejection of syngeneic non-organ-related tumor cells. Cancer Res 2000;60:6696-703.
2. Curti A, Parenza M, Colombo MP. Autologous and MHC class I-negative allogeneic tumor cells secreting IL-12 together cure disseminated A20 lymphoma. Blood 2003;101:568-75.
3. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993;53:5274-83.
4. Bi W, Kim YG, Feliciano ES, Pavelic L, Wilson KM, Pavelic ZP, Stambrook PJ. An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice. Cancer Gene Ther 1997;4:246-52.
5. Dilber MS, Abedi MR, Bjorkstrand B, Christensson B, Gahrton G, Xanthopoulos KG, Smith CI. Suicide gene therapy for plasma cell tumors. Blood 1996;88:2192-200.
6. Dilber MS, Abedi MR, Christensson B, Bjorkstrand B, Kidder GM, Naus CC, Gahrton G, Smith CI. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res 1997;57:1523-8.
7. Barresi V, Belluardo N, Sipione S, Mudo G, Cattaneo E, Condorelli DF. Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy. Cancer Gene Ther 2003;10:396-402.
8. Pierrefite-Carle V, Gavelli A, Brossette N, Baque P, Benchimol D, Bourgeon A, Staccini P, Rossi B. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect. J Natl Cancer Inst 1999;9:2014-201.
9. Little JB. Genomic instability and bystander effects: a historical per-spective. Oncogene 2003;22:6978-87.
10. Morgan WF, Hartmann A, Limoli CL, Nagar S, Ponnaiya B. Bystander effects in radiation-induced genomic instability. Mutat Res 2002;504:91-100.
11. Lorimore SA, Wright EG. Radiation-induced genomic instability and bystander effects: related inflammatory-type responses to radiation-induced stress and injury? A review. Int J Radiat Biol 2003;79:15-25.
12. Hall EJ. The bystander effect. Health Phys 2003;85:31-5.
13. Azzara EI, de Toledo SM, Little JB. Stress signaling from irradiated to non-irradiated cells. Curr Cancer Drug Targets 2004;4:53-64.
14. Lyng FM, Seymour CB, Mothersill C. Initiation of apoptosis in cells exposed to medium from the progeny of irradiated cells: a possible mechanism for bystander-induced genomic instability? Radiat Res 2002;157:365-70.
15. Ohba K, Omagari K, Nakamura T, Ikuno N, Saeki S, Matsuo I, Kinoshita H, Masuda J, Hazama H, Sakamoto I, Kohno S. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut 1998;43:575-7.
16. 1210B cells treated with nitrogen mustard, 1,3-bis (2-chloroethyl)-1-nitrosourea, and other nitrosoureas. Cancer Res 1997;37:2114-22.
17. 6P-alkyl-transferase purified from human leukemic lymphoblasts. Cancer Res 1987;47:3384-7.
18. Morvan D, Demidem A, Papon J, De Latour M, Madelmont JC. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. Cancer Res 2002;62:1890-7.
19. Limoli CL, Kaplan MI, Phillips JW, Adair GM, Morgan WF. Differential induction of chromosomal instability by DNA strand-breaking agents. Cancer Res 1997;57:4048-56.
20. Demidem A, Morvan D, Papon J, De Latour M, Madelmont JC. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model. Cancer Res 2001;61:2294-300.
21. Spang-Thomsen M, Nielsen Z, Visfeldt J. Growth curves of three human malignant tumours transplanted to nude mice. Exp Cell Biol 1980;48:138-54.
22. Morvan D, Demidem A, Papon J, Madelmont JC. Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl-nitrosourea: demonstration of phospholipid metabolism alterations. Magn Reson Med 2003;49:241-48.
23. Emoto K, Umeda M. Membrane lipid control of cytokinesis. Cell Struct Funct 2001;26:659-65.
24. Krief S, Faivre JF, Robert P, Le Douarin B, Brument-Larignon N, Lefrere I, Bouzyk MM, Anderson KM, Greller LD, Tobin FL, Souchet M, Bril A. Identification and characterization of cvHsp. A novel human small stress protein selectively expressed in cardiovascular and insulin-sensitive tissues. J Biol Chem 1999;274:36592-600.
25. Roovers K, Assoian RK. Effects of Rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G(1) phase cyclin-dependent kinases. Mol Cell Biol 2003;23:4283-94.
26. Nobes CD, Lauritzen I, Mattei MG, Paris S, Hall A, Chardin P. A new member of the Rho family, Rnd1, promotes disassembly of actin filament structures and loss of cell adhesion. J Cell Biol 1998;141:187-97.
27. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998;279: 509-14.
28. Kiss Z. Regulation of mitogenesis by water-soluble phospholipid intermediates. Cell Signal 1999;11:149-57.
29. Griffin JL, Lehtimaki KK, Valonen PK, Grohn OH, Kettunen MI, Yla-Herttuala S, Pitkanen A, Nicholson JK, Kauppinen RA. Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death. Cancer Res 2003;63:3195-201.
30. Das UN. A radical approach to cancer. Med Sci Monit 2002;8:RA79-RA92.
31. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 2003;57:145-55.
32. Wilhelm D, Bender K, Knebel A, Angel PL. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol Cell Biol 1997;17:4792-800.
33. Ortega A, Ferrer P, Carretero J, Obrador E, Asensi M, Pellicer JA, Estrela JM. Down-regulation of glutathione and Bcl-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium. J Biol Chem 2003;278:39591-9.
34. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2002;3:401-10.
35. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002;94:883-93.
36. Andreassen PR, Lohez OD, Margolis RL. G2 and spindle assembly checkpoint adaptation, and tetraploidy arrest: implications for intrinsic and chemically-induced genomic instability. Mutat Res 2003;532:245-53.
37. Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan MP, Grant S, Schmidt-Ullrich R. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res 2003;159:283-300.
38. Trakul N, Menard RE, Schade GR, Qian Z, Rosner MR. Raf kinase inhibitory protein regulates raf-1 but not B-raf kinase activation. J Biol Chem 2005;280:24931-40.
39. Wang X, Li N, Liu B, Sun H, Chen T, Li H, Qiu J, Zhang L, Wan T, Cao X. A novel human PEBP resists TNFα-induced apoptosis by inhibiting MAPK pathway activation and PE externalization. J Biol Chem 2004;173:3467-81.
40. Mehlen P, Kretz-Remy C, Preville X, Arrigo AP. Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death. EMBO J. 1996;15:2695-706.
41. Aldrian S, Trautinger F, Frohlich I, Berger W, Micksche M, Kindas-Mugge I. Overexpression of Hsp27 affects the metastatic phenotype of human melanoma cells in vitro. Cell Stress Chaperones 2002;7:177-85.
42. Iyer R, Lehnert BE. Factors underlying the cell growth-related bystander responses to alpha particles. Cancer Res 2000;60:1290-8.
43. Narayanan PK, LaRue KE, Goodwin EH, Lehnert BE. Alpha particles induce the production of interleukin-8 by human cells. Radiat Res 1999;152:57-63.